Hummingbird AI is now live! Sign up here.

PRESS & FEATURES

Brightseed in
the News

Read more about the impact of bioactives on human health in articles and scientific papers. For media inquiries, please contact press@brightseedbio.com.

Press Release

Brightseed Launches Hummingbird™, Advancing Its AI-Powered Innovation Platform from Discovery to Development

Press Release

Brightseed Expands World’s Largest Proprietary Bioactive Dataset to 21 Million Compounds, Strengthening AI-Native Innovation Platform

Press Release

Evra ingredients and Brightseed Partner to Unlock Next-Generation Natural Ingredients with AI-Powered Discovery

Press Release

Brightseed Launches the World’s First Clinically-Validated, Enterprise AI Platform, Built On Over A Decade Of Scientific Research

Company Update

Building the World’s Most Comprehensive Bioactive Intelligence Platform: A Candid Conversation with Our Co-founder and Chairman, Sofia Elizondo

Company Update

From AI Discovery to Dynamic Clinical Proof: Our Second Peer-Reviewed Study on Continuous Glucose Monitoring

Press Release

Brightseed Publishes Second Peer-Reviewed Publication of a Clinical Study Demonstrating AI-Discovered Bioactives Significantly Improve Continuous Glucose Monitoring

Nutrition Insight

Brightseed bioactive ingredient shows potential glucose stability post GLP-1 use
Measuring

Company Update

A New Peer-Reviewed Study Shows How Bioactives Can Support Healthy Blood Glucose Regulation

Company Update

Brightseed’s 2025 Year in Review

NutraIngredients

Brightseed launches BioMetaControl for blood sugar control and metabolic health

Press Release

Brightseed Launches BioMetaControl™, a Nature-Inspired GLP-1 Companion for Metabolic Health